logo
Share SHARE
FONT-SIZE Plus   Neg

Peregrine Presents Data From Phase IIb Trial In Patients With Refractory NSCLC

Peregrine Pharmaceuticals Inc. (PPHM) announced that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients with refractory non-small cell lung cancer or NSCLC.

The company noted that the blinded study evaluated two dose levels of bavituximab (bavituximab-containing arms) given with docetaxel versus docetaxel plus placebo (control arm). The interim data showed a statistically significant improvement in overall survival (Hazard Ratio 0.524, p-value .0154) and a doubling of median overall survival or OS in the bavituximab-containing arms compared to the control arm.

The trial enrolled 121 patients (117 evaluable per the study protocol) with second-line non-squamous NSCLC following one prior chemotherapy regimen at over 40 clinical centers. Patients were equally randomized to 1 of the 3 treatment arms, docetaxel (75mg/m2) plus either placebo, 1 mg/kg bavituximab, or 3 mg/kg bavituximab until disease progression. Approximately 50% of the patients were enrolled in the U.S. and 50% were enrolled internationally with equal distribution between all treatment groups.

The company noted that the interim results from the study showed no significant safety differences between the three treatment arms as determined by the trial's independent data monitoring committee. Baseline characteristics were well balanced across all three treatment arms of the study, including performance or ECOG status, age, gender, and race. Tumor responses were determined in accordance with Response Evaluation Criteria In Solid Tumors (RECIST 1.1) based on blinded central radiology review.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
PowerBar has selected Olympic swimmer Ryan Lochte for its ad campaign to kick start the "Clean Start Pledge." The energy bar's ad campaign, which focuses on its newer line of "Clean Whey" protein bars, also encourages consumers to participate in sports and fitness exercises to improve their health. The Clean Start Pledge started on January 18. Comedian Jerry Seinfeld has signed a new production deal with Netflix Inc. that will make the online video streaming service the exclusive home for his new comedic projects. As part of Seinfeld's exclusive deal with Netflix, twenty four brand new episodes of "Comedians in Cars Getting Coffee" will being streaming exclusively on Netflix in installments in late 2017. Food delivery startup DoorDash and courier service Postmates have joined with robotic delivery developer Starship Technologies for conducting commercial delivery trials over the next few weeks. With Starship's self-driving delivery robots, DoorDash will do the delivery tests in Redwood City, California, while Postmates' tests will take place in Washington, D.C. They will carry food orders ...
comments powered by Disqus
Follow RTT